表紙
市場調査レポート

癌・腫瘍プロファイリングの世界市場 - 適用分野(オーダーメイド医療、診断、バイオマーカー開発、予後診断、研究)、技術(NGS、QPCR、IHC、FISH/CISH、マイクロアレイ)および研究セグメント(ゲノミクス、プロテオミクス、メタボロミクス、エピジェネティックス)別分析

Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018

発行 MarketsandMarkets 商品コード 284535
出版日 ページ情報 英文 173 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。
Back to Top
癌・腫瘍プロファイリングの世界市場 - 適用分野(オーダーメイド医療、診断、バイオマーカー開発、予後診断、研究)、技術(NGS、QPCR、IHC、FISH/CISH、マイクロアレイ)および研究セグメント(ゲノミクス、プロテオミクス、メタボロミクス、エピジェネティックス)別分析 Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018
出版日: 2013年09月30日 ページ情報: 英文 173 Pages
概要

癌プロファイリングはヘルスケア産業の中でも著しい成長が見込まれる有望市場であり、バイオマーカーの発見や予後診断をはじめ、広範な適用分野で急発展する勢いを見せています。2013年の世界市場は149億9000万ドル規模。2018年には350億3000ドルの価額に達する見通しです。

当レポートでは、こうした癌・腫瘍プロファイリングの世界市場に注目し、2013-2108年の期間を対象に、その推移を適用分野、技術、セグメントおよび地域別に予測するほか、発展を推進・抑制するそれぞれの要因、成長への機会と課題、競合環境、主要参入企業など同市場についての最新情報を集め、概略以下の構成でお届けします。

第1章 イントロダクション

  • 重要所見
  • 信頼できる情報源に基く当調査の論理的仮定
  • レポートの対象範囲
  • 調査方法
    • 一次・二次情報源から得られたデータの重要ポイント

第2章 エグゼクティブサマリー

第3章 腫瘍プロファイリングの技術環境

  • 技術概要
  • 癌研究におけるマイルストーン
  • 腫瘍プリファイリングのセグメント
    • ゲノミクス
    • プロテオミクス
    • メタボロミクス
    • エピジェネティックス
  • 接尾辞「-omes」の生物学研究体系
  • 腫瘍プロファイリング技術
    • 次世代シークエンシング(NGS)
    • 蛍光・発色in situハイブリッド形成法(FISH/CISH)
    • 免疫組織化学(IHC)
    • マイクロアレイ
    • 定量ポリメラーゼ連鎖反応(QPCR)
    • 主な腫瘍プロファイリング技術革新
    • 市場における主な腫瘍プロファイリング製品・サービス

第4章 腫瘍プロファイリング研究ポートフォリオ

  • 腫瘍プロファイリング研究ネットワーク

第5章 バリューチェーン分析

  • 概要
  • 主な利害関係者
  • ギャップ分析
  • Porterのファイブフォース分析

第6章 市場環境分析

  • 腫瘍プロファイリング技術:市場セグメンテーション
  • 腫瘍プロファイリング技術:世界的影響
  • 市場予測:概要 - 2013-2018年
  • 世界の癌プロファイリング:市場収益予測 - 2013-2018年
    • 世界の癌プロファイリング:市場収益 - 地域別
    • 世界の癌プロファイリング:市場シェア - 地域別
    • 世界の癌プロファイリング:市場収益 - セグメント別
    • 世界の癌プロファイリング:市場収益 - 技術別
    • 世界の癌プロファイリング:市場収益 - 適用分野別
  • 市場動態
    • 推進要因
      • 腫瘍プロファイリング - 推進要因の影響力分析
    • 抑制要因
      • 腫瘍プロファイリング - 抑制要因の影響力分析

第7章 技術導入と発展性 - 地域別

  • 地域別導入状況および発展性 - 概要
  • 北米
  • 欧州
  • アジア
  • その他の地域

第8章 技術投資分析

  • 投資環境評価
  • 投資家ネットワーク
  • 癌・腫瘍プロファイリングの資金と投資
  • 国立衛生研究所からの資金および投資 - 年度別
  • 国立衛生研究所からの資金および投資 - 同研究所関連機関・センターによるもの(2008-2013年)
  • 国立衛生研究所から高額資金提供を受けた上位10組織(2008-2013年)
  • 各種癌研究を対象とした米国癌協会からの資金(2013年9月1日現在)
  • 現在および将来の技術投資トレンドについての考察

第9章 競合環境分析

  • 競合環境分析
  • 主な企業買収、提携、協定、協力関係
  • 利害関係者にとってライセンシング、買収に利用可能な技術

第10章 特許分析

  • 概要
  • 知財競争力解析 - 癌セグメント別

第11章 アナリストの考察と提言

  • 市場に対する主な考察
  • 戦略的提言
  • 事業展開に向けて当該分野での機会を率直に提言

第12章 企業プロフィール

目次
Product Code: BT 2123

Cancer profiling is a promising market and is witnessing significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global market is valued at $14.99 billion in 2013 and is expected to reach $35.03 billion by 2018.

A list of tests (for example, Barium X-ray, Blood tests, Bone marrow, Cystoscopy, Lumbar puncture) is available, used for diagnosing specific types of cancer. Also, there are different treatment options for cancer, including chemotherapy, hormone therapy, surgery, radiotherapy, bisphosphonates, bone marrow and stem cell transplants, and biological therapies. Despite the availability of different treatment options, profiling a tumor, that is, knowledge about a patient's cancer profile may identify genomic alterations that will help the physician to guide the patient to a systemic therapy with a higher likelihood of success. This will rule out those that are unlikely to be successful, on an individual basis, thereby minimizing the trial and error process.

Every cancer cell has got its own pattern of active genes and proteins; therefore, molecular profiling tests for a number of different biomarkers in the DNA of a tissue sample will assist in better diagnosing and staging the cancer on an individual basis. This provides the doctors with better information to develop a personalized treatment plan for a patient, which is known as personalized medicine.

There are quite a number of research groups working on diverse applications of tumor profiling targeting different cancer types, particularly in studying key target molecules involved in the pathogenesis. Hundreds of research articles have been published and a lot of patents granted and filed for this field of biology.

The market is analyzed both in terms of qualitative, that is, technological and quantitative, that is, revenue and perspectives. The technological analysis includes discussion on the advantages and capabilities of cancer profiling technologies and the various applications where tumor profiling can find a strong position in the healthcare industry. The market revenue analysis includes market segmentation and the expected market position by 2018, with the projected growth rate.

The market is classified by geography, applications, technologies, and segment types. The technologies section is further segmented into Next-Generation Sequencing, Quantitative PCR, Immunohistochemistry, FISH/CISH, and Microarray. Though personalized medicine is highlighted as the prime application area of cancer/tumor profiling, there are many opportunities in Diagnostics, Biomarker Discovery, Prognosis, and Research applications.

Besides a discussion on the properties and advantages of cancer profiling in the technological analysis, the basics on the correlation of cancer with genomics, proteomics, Metabolomics, and epigenetics are also discussed. Further, the research network including academic universities and biotech companies with their research contributions are also provided. The complete value chain of the tumor profiling market is schematically represented and the significance of each stakeholder has been briefed.

Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards the cancer profiling. Insights on current and future technological investment trends have also been discussed.

The adoption and developmental potential of this technology market has been discussed on a geographic basis, that is, North America, Europe, Asia, and Rest of the World, by taking select countries that are poised to have a greater market value during the forecast period.

In brief, this research report provides:

  • 1. A detailed description of the global technology developments and evolving trends in the cancer profiling field with key importance on research innovations, collaborative efforts, and investments for tumor profiling
  • 2. An impact analysis of major drivers and restraints influencing the adoption and growth of the cancer profiling market from 2013 to 2018
  • 3. Porter's five forces analysis and GAP analysis
  • 4. Market size - global market forecast for 2013-2018 analysis and strategic recommendations for technology/product developers
  • 5. Competitive landscape, including key industry activities (for example, mergers, acquisitions, partnerships, collaborations, and agreements) and an analysis of key patents on the segment types.

Scope of the Report

This research report categorizes the global market into geography, applications, technologies, and segment types. The applications, technologies, and segments market is further broken down by geography, with an exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2018.

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

By Applications

  • Personalized Medicine
  • Diagnostics
  • Biomarker discovery
  • Prognosis
  • Research applications

By Technologies

  • Next-Generation Sequencing
  • Quantitative PCR
  • Immunohistochemistry
  • FISH/CISH
  • Microarray

By Applications

  • Genomics
  • Proteomics
  • Metabolomics
  • Epigenetics

Table of Contents

1. Introduction

  • 1.1. Key Take-Aways
  • 1.2. Logical Assumptions For This Study Based On Reliable Sources
  • 1.3. Report Scope
  • 1.4. Research Methodology
  • 1.5. Key Data Points From Secondary & Primary Resources

2. Executive Summary

3. Tumor Profiling Technology Landscape

  • 3.1. Technology Overview
  • 3.2. Milestones In Cancer Research
  • 3.3. Tumor Profiling Segments
    • 3.3.1. Genomics
    • 3.3.2. Proteomics
    • 3.3.3. Metabolomics
    • 3.3.4. Epigenetics
      • 3.3.4.1. Epigenetic Genes Disturbed In Cancer Conditions
      • 3.3.4.2. Cancers And Associated Epigenetic Disruptions
  • 3.4. The Biological Organization Of The “-Omes”
  • 3.5. Tumor Profiling Technologies
    • 3.5.1. Next-Generation Sequencing (NGS)
    • 3.5.2. Fluorescence/Chromogenic In Situ Hybridization (Fish/Cish)
    • 3.5.3. Immunohistochemistry (IHC)
    • 3.5.4. Microarray
    • 3.5.5. Quantitative Pcr (QPCR)
  • 3.6. Key Tumor Profiling Technological Innovations
  • 3.7. Key Tumor Profiling Products & Services In The Market

4. Tumor Profiling Research Portfolio

  • 4.1. Tumor Profiling Research Network

5. Value Chain Analysis

  • 5.1. Overview
  • 5.2. Key Stakeholders
  • 5.3. Gap Analysis
  • 5.4. Porter's Five Forces Analysis

6. Market Landscape Analysis

  • 6.1. "Tumor Profiling Technologies: Market Segmentation"
  • 6.2. "Tumor Profiling Technologies: Global Impact
  • 6.3. Market Forecast: Overview, 2013-2018
  • 6.4. "Global Cancer Profiling: Market Revenue Forecast, 2013 - 2018"
    • 6.4.1. "Global Cancer Profiling: Market Revenue, By Geography"
    • 6.4.2. Global Cancer Profiling Market Share, By Geography
    • 6.4.3. Global Cancer Profiling: Market Revenue, By Segment
      • 6.4.3.1. Global Cancer Profiling: Market Share, By Segment
      • 6.4.3.2. Genomics Market, By Region
      • 6.4.3.3. Proteomics Market, By Region
      • 6.4.3.4. Metabolomics Market, By Region
      • 6.4.3.5. Epigenetics Market, By Region
    • 6.4.4. Global Cancer Profiling Market Revenue, By Technology
      • 6.4.4.1. Global Cancer Profiling Market Share, By Technology
      • 6.4.4.2. Next-Generation Sequencing Market, By Region
      • 6.4.4.3. Fluorescence/Chromogenic In Situ Hybridization Market, By Region
      • 6.4.4.4. Immunohistochemistry Market, By Region
      • 6.4.4.5. Quantitative Pcr Market, By Region
      • 6.4.4.6. Microarray Market, By Region
    • 6.4.5. Global Cancer Profiling Market Revenue, By Application
      • 6.4.5.1. Global Cancer Profiling Market Share, By Application
      • 6.4.5.2. Personalized Medicine Market, By Region
      • 6.4.5.3. Biomarker Discovery Market, By Region
      • 6.4.5.4. Diagnostics Market, By Region
      • 6.4.5.5. Prognosis Market, By Region
      • 6.4.5.6. Research Applications Market, By Region
  • 6.5. Market Dynamics
    • 6.5.1. Drivers
      • 6.5.1.1. Tumor Profiling - Impact Analysis Of Drivers
    • 6.5.2. Restraints
      • 6.5.2.1. Tumor Profiling - Impact Analysis Of Restraints

7. Technology Adoption And Development Potential, By Geography

  • 7.1. Geographic Adoption And Development Potential - Overview
  • 7.2. North America
  • 7.3. Europe
  • 7.4. Asia
  • 7.5. Rest Of The World (ROW)

8. Technology Investment Analysis

  • 8.1. Investment Climate Assessment
  • 8.2. Investor Network
  • 8.3. Funds And Investments On Cancer/Tumor Profiling
  • 8.4. Funds And Investments From Nih - By Fiscal Year
  • 8.5. Funds And Investments From Nih - By Its Associated Institutes/Centers (2008 - 2013)
  • 8.6. Top 10 Organizations To Receive Highest Funding From Nih During 2008-2013
  • 8.7. Funds From The American Cancer Society As Of September 01, 2013 For Various Cancer Types
  • 8.8. Insights On Current And Future Technology Investment Trends

9. Competitive Landscape Analysis

  • 9.1. Competitive Landscape Analysis
  • 9.2. Key Acquisitions/Partnerships/Agreements/Collaborations (2010-2013)
  • 9.3. Technologies Available For Licensing & Acquisition For Stakeholders

10. Patent Analysis

  • 10.1. Overview
  • 10.2. Ip Strength Analysis - By Cancer Segments

11. Analyst Insights And Recommendations

  • 11.1. Key Insights On The Market
  • 11.2. Strategic Recommendations
  • 11.3. Open Opportunity Invitations In The Field For Business Development

12. Company Profiles

  • 12.1. Boreal Genomics, Inc.
  • 12.2. Caris Life Sciences
  • 12.3. Genomic Health, Inc.
  • 12.4. Illumina, Inc.
  • 12.5. Life Technologies Corporation
  • 12.6. Neogenomics Laboratories
  • 12.7. Oxford Gene Technology Ltd
  • 12.8. Precision Therapeutics, Inc.
  • 12.9. Biotheranostics
  • 12.10. Proteome Sciences Plc
  • 12.11. Agendia Nv
  • 12.12. Nanostring Technologies
  • 12.13. Rational Therapeutics
  • 12.14. Oncopath Laboratory
  • 12.15. Ribomed Biotechnologies

List Of Tables

  • Tab - 1: Global Tumor Profiling Market, 2013 - 2018 ($Billion)
  • Tab - 2: Global Tumor Profiling: Market Revenue, By Geography, 2013 - 2018 ($Billion)
  • Tab - 3: Global Tumor Profiling Market, By Segment, 2013 - 2018 ($Billion)
  • Tab - 4: Genomics Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 5: Proteomics Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 6: Metabolomics Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 7: Epigenetics Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 8: Global Cancer Profiling Market, By Technology, 2013 - 2018 ($Billion)
  • Tab - 9: Next Generation Sequencing Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 10: Fluorescence/Chromogenic In Situ Hybridization Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 11: Immunohistochemistrymarket, By Region, 2013 - 2018 ($Billion)
  • Tab - 12: Quantitative PCR, By Region, 2013 - 2018 ($Billion)
  • Tab - 13: Microarray Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 14: Global Tumor Profiling Market, By Application, 2013 - 2018 ($Billion)
  • Tab - 15: Personalized Medicine Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 16: Biomarker Discovery Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 17: Diagnostics Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 18: Prognosis Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 19: Research Applications Market, By Region, 2013 - 2018 ($Billion)
  • Tab - 20: Funds By Nih & Its Associated Centers, 2008-2013 ($Million)
  • Tab - 21: Projects And Funds By Nih & Its Associated Centers, 2008-2013 ($Million)
  • Tab - 22: Projects And Funds From The American Cancer Society As Of Sep 01, 2013 ($Million)

List Of Figures

  • Fig - 1: Global Tumor Profiling Market, 2013 - 2018 ($Billion)
  • Fig - 2: Porter's Value Chain Analysis For The Cancer Profiling Market
  • Fig - 3: Global Cancer Profiling Market, 2013 - 2018 ($Billion)
  • Fig - 4: Global Cancer Profiling: Market Revenue, By Geography, 2013 - 2018 ($Billion)
  • Fig - 5: Global Cancer Profiling Market, By Geography, 2012 - 2018
  • Fig - 6: Global Cancer Profiling Market By Segment, 2013 - 2018 ($Billion)
  • Fig - 7: Global Cancer Profiling Market: Growth Rate, By Segment, 2013 - 2018
  • Fig - 8: Global Cancer Profiling Market, By Segment, 2013 - 2018
  • Fig - 9: Genomics Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 10: Genomics Market, By Region, 2013 - 2018
  • Fig - 11: Proteomics Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 12: Proteomics Market, By Region, 2013 - 2018
  • Fig - 13: Metabolomics Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 14: Metabolomics Market, By Region, 2013 - 2018
  • Fig - 15: Epigenetics Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 16: Epigenetics Market, By Region, 2013 - 2018
  • Fig - 17: Global Cancer Profiling Market, By Technology, 2012 - 2018 ($Billion)
  • Fig - 18: Global Cancer Profiling Market, By Technology, 2012 - 2018
  • Fig - 19: Global Cancer Profiling Market, By Technology, 2013 - 2018
  • Fig - 20: Next Generation Sequencing Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 21: Next-Generation Sequencing Market, By Region, 2013 - 2018
  • Fig - 22: Fluorescence/Chromogenic In Situ Hybridization Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 23: Fluorescence/Chromogenic In Situ Hybridization Market, By Region, 2013 - 2018
  • Fig - 24: Immunohistochemistrymarket, By Region, 2013 - 2018 ($Billion)
  • Fig - 25: Immunohistochemistry Market, By Region, 2013 - 2018
  • Fig - 26: Quantitative Pcr, By Region, 2013 - 2018 ($Billion)
  • Fig - 27: Quantitative Pcr Market, By Region, 2013 - 2018
  • Fig - 28: Microarray Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 29: Microarray Market, By Region, 2013 - 2018
  • Fig - 30: Global Cancer Profiling Market, By Application, 2012 - 2018 ($Billion)
  • Fig - 31: Global Cancer Profiling Market Share , By Application, 2012 - 2018
  • Fig - 32: Global Cancer Profiling Market, By Application, 2013 - 2018
  • Fig - 33: Personalized Medicine Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 34: Personalized Medicine Market, By Region, 2013 - 2018
  • Fig - 35: Biomarker Discovery Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 36: Biomarker Discovery Market, By Region, 2013 - 2018
  • Fig - 37: Diagnostics Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 38: Diagnostics Market, By Region, 2013 - 2018
  • Fig - 39: Prognosis Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 40: Prognosis Market, By Region, 2013 - 2018
  • Fig - 41: Research Applications Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 42: Research Applicatons Market, By Region, 2013 - 2018
  • Fig - 43: Tumor Profiling - Market Dynamics
  • Fig - 44: Tumor Profiling Market Cagr, By Geography, 2013 - 2018
  • Fig - 45: Metabolomics Market, By Region, 2013 - 2018 ($Billion)
  • Fig - 46: Funding By Nih & Its Associated Centers, 2008-2013 ($Million)
  • Fig - 47: Funding By Nih & Its Associated Centers, 2008-2013 ($Million)
  • Fig - 48: Funding By American Cancer Society ($Million)
  • Fig - 49: Total No. Of Patents Filed, By Cancer Segments
  • Fig - 50: Cancer Segments Ip Share In 2013
Back to Top